Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Carl Zeiss Meditec AG    AFX   DE0005313704

CARL ZEISS MEDITEC AG

(AFX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
10/23/2020 10/26/2020 10/27/2020 10/28/2020 10/29/2020 Date
118.7(c) 116.2(c) 115.8(c) 112.6(c) 109.5(c) Last
215 714 141 517 169 656 215 518 268 827 Volume
-2.55% -2.11% -0.34% -2.76% -2.75% Change
More quotes
Financials
Sales 2020 1 372 M 1 602 M 1 602 M
Net income 2020 121 M 141 M 141 M
Net cash position 2020 556 M 650 M 650 M
P/E ratio 2020 78,2x
Yield 2020 0,50%
Sales 2021 1 484 M 1 733 M 1 733 M
Net income 2021 165 M 193 M 193 M
Net cash position 2021 651 M 760 M 760 M
P/E ratio 2021 61,0x
Yield 2021 0,63%
Capitalization 9 794 M 11 420 M 11 437 M
EV / Sales 2020 6,73x
EV / Sales 2021 6,16x
Nbr of Employees 3 335
Free-Float 40,9%
More Financials
Company
Carl Zeiss Meditec AG specializes in the production and marketing of ophthalmologic diagnosis systems and equipment. The group also manufactures and sells microsurgical visualization systems and ophthalmic surgery equipment. Net sales break down by family of products as follows: - ophthalmologic diagnosis systems and equipment (73.2%): slit lamps, corneal topography systems, retinal imaging systems, keratometers,... 
More about the company
Notations Surperformance© of Carl Zeiss Meditec AG
Trading Rating : Investor Rating :
More Ratings
All news about CARL ZEISS MEDITEC AG
10/29CARL ZEISS MEDITEC : Ad Hoc Announcement 29-Oct-2020
PU
10/29CARL ZEISS MEDITEC AG : Berenberg reiterates its Neutral rating
MD
10/29CARL ZEISS MEDITEC : concludes fiscal year 2019/20 with a recovery in profit in ..
EQ
10/23CARL ZEISS MEDITEC AG : UBS is now Neutral
MD
10/23CARL ZEISS MEDITEC AG : Hauck & Aufhauser gives a Neutral rating
MD
10/06CARL ZEISS MEDITEC AG : Hauck & Aufhauser reaffirms its Buy rating
MD
09/23CARL ZEISS MEDITEC AG : Gets a Neutral rating from Berenberg
MD
09/18CARL ZEISS MEDITEC AG : Hauck & Aufhauser reiterates its Buy rating
MD
09/11CARL ZEISS MEDITEC : ZEISS Medical Technology Nominated for Deutscher Zukunftspr..
AQ
09/07CARL ZEISS MEDITEC AG : Notification and public disclosure of transactions by pe..
EQ
09/02CARL ZEISS MEDITEC AG : From Neutral to Buy by Hauck & Aufhauser
MD
08/27CARL ZEISS MEDITEC : Effectiveness and efficiency of targeted intra-operative si..
AQ
08/19CARL ZEISS MEDITEC AG : Independant Research maintains a Sell rating
MD
08/10CARL ZEISS MEDITEC AG : DZ Bank lowers its rating to Sell
MD
08/10CARL ZEISS MEDITEC AG : NorldLB reiterates its Buy rating
MD
More news
News in other languages on CARL ZEISS MEDITEC AG
10/29Aktien Frankfurt Schluss: Dax schliesst nach Achterbahnfahrt im Plus
10/29CARL ZEISS MEDITEC : Ad hoc Mitteilung 29.10.2020
10/29CARL ZEISS MEDITEC AG : Berenberg est neutre sur le titre
10/29Berenberg belässt Carl Zeiss Meditec auf 'Hold' - Ziel 87 Euro
10/29DPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 29.10.2020 - 15.15 Uhr
More news
Analyst Recommendations on CARL ZEISS MEDITEC AG
More recommendations
Chart CARL ZEISS MEDITEC AG
Duration : Period :
Carl Zeiss Meditec AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CARL ZEISS MEDITEC AG
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Average target price 101,08 €
Last Close Price 109,50 €
Spread / Highest target 32,4%
Spread / Average Target -7,69%
Spread / Lowest Target -52,5%
EPS Revisions
Managers
NameTitle
Ludwin Monz President & Chief Executive Officer
Michael Kaschke Chairman-Supervisory Board
Justus Felix Wehmer Chief Financial Officer
Markus Guthoff Member-Supervisory Board
Cornelia Grandy Member-Supervisory Board
Sector and Competitors